With the convergence of scientific advancements and compassionate care, a new chapter in addiction treatment is unfolding. Explore the potential of intravenous NAD+ infusions and GLP-1 agonists—unlocking pathways to lasting recovery and renewed hope.
Unlocking the Potential of Intravenous NAD+ and GLP-1 Agonists for Addiction Recovery
Alcohol Use Disorder (AUD) is a complex challenge affecting millions globally, yet effective treatments remain limited. But now, emerging research sheds light on promising avenues for detoxification, recovery, and sustained abstinence.
Innovative approaches utilizing intravenous NAD+ infusions and GLP-1 agonists offer new hope in battling addiction. GLP-1 agonists, Semiglutide, exhibit remarkable potential in reducing alcohol intake by acting on key brain regions associated with reward pathways.
Research suggests that GLP-1 agonists not only modulate the brain’s response to alcohol but may also influence appetite and gastric emptying, potentially curbing cravings and consumption.
Meanwhile, the therapeutic prowess of NAD+ in addiction treatment has been underscored by groundbreaking studies. Administered intravenously, NAD+ has shown remarkable efficacy in alleviating substance craving behaviors across a spectrum of addictive substances, including alcohol and opioids.
“Simply said, alcohol is a carbohydrate and GLP-1 agonists such as Semiglutide reduce carbohydrate cravings, while NAD+ infusions help to reestablish balance and improve our bodies metabolism” – Dr. Reza Danesh
Early pioneering work by Paul O’ Hollaren has highlighted the transformative impact of IV NAD+ infusions in over a hundred cases of addiction, offering a holistic and cost-effective approach to addressing addiction’s physical and psychological toll.
The ongoing investigation seeks to further validate the effectiveness of NAD+ alongside complementary amino acids in attenuating substance craving behaviors and mitigating associated psychiatric burdens.
Contact us to learn more about our innovative protocols and embark on a journey towards holistic healing and long-term sobriety.
-Kelly Hoffman, RN – MODO MD Wellness Team